Cellbion Co (308430.KQ) Stock Price

Cellbion Co Price

CLOSED
13,580.00
​
Market closed

Revenue has compounded at 20.7% per year over the past 4 years to 1.95 B KRW. Cellbion Co's net margin stands at -389.4%, up from -521.1% several years earlier.

Cellbion Co stock price

Access this data via the Eulerpool API

Cellbion Co business model & stock analysis

Cellbion Co Ltd is a KR-based company operating in industry. The company is headquartered in Seoul, Seoul and currently employs 43 full-time employees. The company went IPO on 2024-10-16. Cellbion Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of pharmaceuticals. The firm is engaged in the development of innovative diagnostic and therapeutic new drugs. The firm is also engaged in the generic prescription drug business. The firm is engaged in the manufacturing organization (CDMO) business for clinical trial drugs. In addition, the Company also manufactures cosmetic products.

Frequently asked questions about Cellbion Co

Converted at the current exchange rate, the Cellbion Co share trades at 9.03 EUR (13,580.00 KRW).

The revenue cannot currently be calculated for Cellbion Co.

The profit cannot currently be calculated for Cellbion Co.

The P/E ratio cannot be calculated for Cellbion Co at the moment.

The P/S cannot be calculated for Cellbion Co currently.

The Eulerpool Quality Score for Cellbion Co is 2/10.

The ISIN of Cellbion Co is KR7308430008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Cellbion Co is 308430.KQ. The ticker symbol is used to trade Cellbion Co shares on the stock exchange.

Fair ValueTerminal
13,987.40 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue per Employee
45.23 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Oct 16, 2024
ISIN
KR7308430008
Cusip
Y12447101
Market capitalization
137.85 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
6.05
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-31.84 %
Last updated Oct 10, 2026, 7:36 PM

Cellbion Co Peer Group

All fundamentals and in-depth analysis of Cellbion Co

Our stock analysis for Cellbion Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cellbion Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.